Main Session 2: The EURETINA Guidelines for Management of Retinal Disease

Chairpersons:U. Schmidt-Erfurth AUSTRIA , A. Grzybowski POLAND

 

U. Schmidt-Erfurth AUSTRIA
Where is anti-VEGF therapy now: achievements and challenges

E. Midena ITALY 
Neovascular AMD: the ten key messages

F. Bandello ITALY
Diabetic macular edema: the ten key messages

A. Loewenstein ISRAEL
Vein occlusion: the ten key messages

A. Grzybowski POLAND
A state-of-the-art in endophthalmitis in anti-VEGF therapy

D. Martin USA
The future needs and progress in anti-VEGF therapy

 

Discussion

End of session

Back

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved